Healthcare Global Enterprises has announced the approval of its unaudited financial results for Q3 2026. Additionally, the board has approved the introduction of the HCG Employee Stock Option Scheme, 2026 (HCG ESOS 2026), subject to shareholder approval. Key leadership appointments were also formalized, including Dr. Naveen R. Nagar as Head – Clinical Strategy and Mr. Pankaj Gautam as Chief Information Officer, enhancing the company’s strategic capabilities.
Financial Performance Overview
Healthcare Global Enterprises (HCG) has officially released and approved the unaudited financial results for the quarter and nine months ending December 31, 2025. These results, which have been reviewed by the board, highlight the company’s financial standing and operational performance. The comprehensive financial details are available for review, providing insights into HCG’s performance during this period. HCG reported a consolidated total income of ₹635.54 million for the quarter.
Introduction of HCG ESOS 2026
The board has approved the implementation of the HCG Employee Stock Option Scheme 2026 (HCG ESOS 2026), designed to grant employee stock options to eligible employees across the company and its subsidiaries. This initiative, pending shareholder and regulatory approvals, aims to align employee interests with the long-term growth of the company. Up to 7,421,455 shares may be issued under this program. The implementation is subject to shareholder approval.
Leadership Appointments
Several key leadership appointments have been formalized to strengthen the company’s strategic direction. Key appointments include: Dr. Naveen R. Nagar, appointed as Head of Clinical Strategy. Mr. Pankaj Gautam, appointed as Chief Information Officer (CIO). Both individuals will serve as Senior Management Personnel, contributing to the company’s ongoing development and strategic initiatives.
Standalone Financial Highlights
The unaudited standalone financial results show a total income of ₹3,451.5 lakhs for Q3 2026. The net profit after tax stood at ₹-7.90 million. Earnings per share (EPS) was reported at ₹-0.08.
Consolidated Financial Highlights
For the three months ended December 31, 2025, the consolidated results highlight a total income of ₹635.54 million. The net profit after tax for the same period stood at ₹-5.82 million. The earnings per share (EPS) for the period were reported at ₹-0.68.
Source: BSE
